20077 ⎘
Medicinal preparations characterised by special physical form; Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles; Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
Water soluble polycarbonates for medical applications
#902Composition for hot melt extrusion and method for producing hot melt extrudate by using same
#903METHODS TO PRODUCE PARTICLES COMPRISING THERAPEUTIC PROTEINS
#904Chemoembolisation
#905Aqueous suspensions of TMC278
#906Oral pharmaceutical composition of isotretinoin
#907Salipro particles
#908NEUTRALLY-CHARGED SYNTHETIC PLATELETS TO MITIGATE COMPLEMENT RESPONSE
#909Yellow reduced pyrroloquinoline quinone crystal and method of producing the same, and food, pharmaceutical, gel, composition and method of producing composition
#910TREATING AGENT AND TREATING METHOD FOR THE EXAMINATION OR OPERATION OF THE LARGE INTESTINE
#911Orally administrable compositions and methods of deterring abuse by intranasal administration
#912PROCESS FOR PREPARING MICROPARTICLES
#913Composition for preventing or treating renal fibrosis comprising dimethylfumarate as active ingredient
#914Urea derivatives and uses thereof
#915Solid dosage form containing arabinogalactan
#916THERAPEUTIC POLYMERIC NANOPARTICLES COMPRISING EPOTHILONE AND METHODS OF MAKING AND USING SAME
#917Mesoporous silica-coated nanoparticles
#918Formulations
#919CELL DELIVERY
#920Particles containing a growth factor, and uses thereof
#921PHARMACEUTICAL COMPOSITION 271
#922Pharmaceutical compositions
#923Formulation of indomethacin
#924Processes for making cyclic lipid implants for intraocular use
#925Oil-in-water method for making polymeric implants containing a hypotensive lipid
#926Cyclodextrin compositions encapsulating a selective ATP inhibitor and uses thereof
#927STABLE GLUCOKINASE ACTIVATOR COMPOSITIONS
#928COMPOSITIONS AND METHODS FOR DELIVERY OF IMMUNE CELLS TO TREAT UN-RESECTABLE OR NON-RESECTED TUMOR CELLS AND TUMOR RELAPSE
#929Pain relieving compositions comprising elemental metals
#930Esterified cellulose ethers of very low viscosity
#931Solid dispersions of low-water solubility actives
#932NANOPARTICLES FOR DERMAL AND SYSTEMIC DELIVERY OF DRUGS
#933SONOLYSIS WITH BIODEGRADABLE NANOPARTICLES
#934Esterified cellulose ethers of very high molecular weight
#935Solid dispersion comprising amorphous cilostazol
#936Method of Engineering Nanoparticle
#937Oral and/or buccal composition in the form of a thin film of a weakly soluble active ingredient, method of preparing same and use of same
#938Pharmaceutical composition for protecting wounds, providing hemostasis, or preventing adhesion in the gastrointestinal tract
#939Ultra low density pulmonary powders
#940Solid dosage form comprising micronized cytisine and its production method
#941PHARMACEUTICAL COMPOSITIONS OF LINEZOLID
#942STABLE AMORPHOUS RALTEGRAVIR POTASSIUM PREMIX AND PROCESS FOR THE PREPARATION THEREOF
#943Hydrophilic matrix beadlet compositions with enhanced bioavailability
#944Pharmaceutical compositions for the treatment of cystic fibrosis transmembrane conductance regulator mediated diseases
#945Powderous formulation
#946NANOPARTICULATE MEGESTROL FORMULATIONS
#947Pharmaceutically acceptable solubilizing composition and pharmaceutical dosage form containing same
#948Microparticles comprising a probiotic, cross-linkable reagent, a denatured protein, polyol plasticiser and trehalose
#949Solid ganaxolone compositions and methods for the making and use thereof
#950Delphinidin complex as an antiphlogistic or immunosuppressive active ingredient
#951Linagliptin solid dispersion
#952Synthesis of hyperbranched amphiphilic polyester and theranostic nanoparticles thereof
#953Amorphous form of apremilast
#954Solid dispersions of insoluble drug and preparation method thereof
#955Bilayered calcium sulfate/calcium phosphate space-making composites with multiple drug delivery capabilities
#956Pharmaceutical composition on the basis of phyto-nutrients with increased bioavailability, having anti-tumor activity, and method for producing said composition (alternatives)
#957ELECTROSTATIC-BONDING-TYPE VESICLE INCLUDING METAL MICROPARTICLES
#958CO-MICRONISATION PRODUCT COMPRISING A SELECTIVE PROGESTERONE-RECEPTOR MODULATOR
#959Method for producing fine powder and the fine powder produced by the same
#960Pharmaceutical composition comprising amphetamines complexed with ion-exchange resin particles
#961Synergistic effect of poloxamer-based composition and itraconazole on fungus and yeast
#962NOVEL HOLLOW PARTICLES
#963Partially absorbable fiber-reinforced composites for controlled drug delivery
#964Pharmaceutical composition
#965Amorphous mirabegron and processes for crystal forms of mirabegron
#966Nanoparticle-insulin and insulin analogue compositions
#967COMPOSITION COMPRISING AN ORGANIC LIQUID DILUENT AND A CELLULOSE ETHER OF VERY LOW VISCOSITY
#968DUAL-TARGETING DRUG CARRIER AND METHOD FOR FABRICATING THE SAME
#969Partially cross-linked esterified cellulose ethers
#970Glycopyrrolate salts
#971POLYMER MATRICES FOR CONTROLLING CRYSTALLIZATION
#972Pharmaceutical compositions providing enhanced drug concentrations
#973Method of making an anhydrous, fat soluble, chewable drug delivery formulation
#974Formulations of cyclopropanecarboxylic acid {2-[(1S)-1-(3-ethoxy-4-methoxy-phenyl)-2-methanesulfonyl-ethyl]-3-oxo-2,3-dihydro-1H-isoindol-4-yl}-amide
#975RECONSTITUTED APOLIPOPROTEIN B LIPOPARTICLE, A PREPARATION METHOD AND USES THEREOF
#976Mass Production and Size Control of Nanoparticles Through Controlled Microvortices
#977Dissolution enhanced controlled drug delivery system for poorly water soluble drugs
#978Solid pharmaceutical composition of cation exchange resin
#979Polymer particles
#980Solid dispersions containing an apoptosis-inducing agent
#981Formulation of diclofenac
#982Implantable polymeric device for sustained release of dopamine agonist
#983Contrast Media Taste Masking Formulations
#984Formulation of diclofenac
#985Cellulose powder
#986Controlled-Released Peptide Formulations
#987Nanoparticle delivery vehicle for S-nitroso-N-acetyl cysteine and uses thereof
#988ELVITEGRAVIR SOLID DISPERSION
#989Gelling agent-based dosage form
#990DOCETAXEL-BASED PROLONGED-RELEASE CANCER TREATMENT DRUG
#991Solid dispersion comprising a highly substituted hydroxyalkyl methylcellulose
#992Polyinosinic-polycytidylic acid (poly (I:C)) formulations for the treatment of upper respiratory tract infections
#993Formulations of rifaximin and uses thereof
#994Injectable particle
#995Crystalline forms of therapeutic compounds and uses thereof
#996Isoxazoline compound composition
#997Nanoparticles of indirubin, derivatives thereof and methods of making and using same
#998Therapeutic Polymeric Nanoparticles Comprising Epothilone and Methods of Making and Using Same
#999DEVICES, COMPOSITIONS, AND METHODS FOR FABRICATING DRUG DELIVERY SYSTEMS
#1000Pharmaceutical composition and use
#1001Nanoparticulate megestrol formulations
#1002Preparation of ticagrelor
#1003Urea derivatives and uses thereof
#1004Carboxylvinyl polymer-containing nanoparticle suspensions
#1005Esterified cellulose ethers having a specific substituent distribution
#1006Nanoparticulate megestrol formulations
#1007Nanoparticulate megestrol formulations
#1008Nanoparticle isoflavone compositions and methods of making and using the same
#1009Extended release pharmaceutical formulations of water-soluble active pharmaceutical ingredients and methods for making the same
#1010Transdermal device including porous microparticles
#1011Co-precipitation method
#1012Hypromellose acetate succinate for use as hot-melt extrusion carrier, hot-melt extrusion composition, and method for producing hot-melt extrudate
#1013Solid ivabradine-containing composition
#1014Method for preparing nano particles
#1015Self-assembled toroidal-spiral particles and manufacture and uses thereof
#1016Method for making homogeneous spray-dried solid amorphous drug dispersions utilizing modified spray-drying apparatus
#1017Solid compositions
#1018PHARMACEUTICAL COMPOSITION AND ADMINISTRATIONS THEREOF
#1019Method of controlling the release of an active ingredient from a dosage form
#1020Methods and compositions for treating post-operative pain comprising a local anesthetic
#1021Testosterone undecanoate compositions
#1022Tamper-resistant dosage form containing ethylene-vinyl acetate polymer
#1023Hydrogel compositions
#1024Composition of a bone repair mixture
#1025Microparticles manufactured in an oil-in-water process comprising a prostamide
#1026Nanoparticulate compositions and formulations of piperazine compounds
#1027Formulations of phenyl uracil compounds
#1028Antibiotic composition for inhalation and irrigation
#1029Preparations containing amorphous emodepside
#1030Composition for hot-melt extrusion and method for producing hot-melt extrusion product using same
#1031Drug loaded polymeric nanoparticles and methods of making and using same
#1032Tamper-resistant dosage form containing one or more particles
#1033Oral dosage forms of methyl hydrogen fumarate and prodrugs thereof
#1034Enzymatic synthesis of poly(amine-co-esters) and methods of use thereof for gene delivery
#1035Pharmaceutical composition for inhalation
#1036CONTROLLED-RELEASE INJECTABLE MICROPARTICLE
#1037NANOPARTICLES WITH ENHANCED MUCOSAL PENETRATION OR DECREASED INFLAMMATION
#1038Organic compound nano-powder, method for producing the same and suspension
#1039Bioactive amphiphilic polymer stabilized nanoparticles with enhanced stability and activity
#1040Pharmaceutical compositions providing enhanced drug concentrations
#1041Composition based on ubidecarenone
#1042Solid retard formulations based on solid dispersions
#1043Nanoparticle compositions for generation of regulatory T cells and treatment of autoimmune diseases and other chronic inflammatory conditions
#1044Sustained release particle formulations
#1045Method for nucleic acid delivery using hyaluronic acid
#1046COMPOSITIONS AND METHODS FOR STABILIZATION OF ACTIVE AGENTS
#1047Orally effective methylphenidate extended release powder and aqueous suspension product
#1048Nanoparticle for targeting brain tumors and delivery of O-benzylguanine
#1049Sulfonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arenaviruses
#1050Abuse deterrent compositions and methods of use
#1051Polymorph compositions, methods of making, and uses thereof
#1052MATRIX-INCORPORATED FLUORESCENT POROUS SILICA PARTICLES FOR DRUG DELIVERY
#1053HIGH-LOADING NANOPARTICLE-BASED FORMULATION FOR WATER-INSOLUBLE STEROIDS
#1054Prostamide-containing intraocular implant
#1055Formulation of indomethacin
#1056Formulation of indomethacin
#1057PHARMACEUTICAL FORMULATION OF NANONIZED FENOFIBRATE
#1058NANOPARTICLE PEPTIDE COMPOSITIONS
#1059Formulation of diclofenac
#1060PHARMACEUTICAL COMPOSITIONS COMPRISING 40 - O - ( 2 - HYDROXY) ETHYL - RAPAMYCIN
#1061Cancer cell targeting using nanoparticles
#1062Physically and chemically stable nicotine-containing particulate material
#1063METHOD OF TREATMENT USING NANOPARTICULATE COMPOSITIONS HAVING LYSOZYME AS A SURFACE STABILIZER
#1064KIT-OF-PARTS
#1065Abuse-deterrent pharmaceutical compositions for controlled release
#1066Formulation of diclofenac
#1067Composition containing S-adenosyl-L-methionine with excellent storage stability
#1068DELIVERY SYSTEM
#1069Method of preparing carrier liquids
#1070Pharmaceutical compositions of dispersions of drug and neutral polymers
#1071PROCESS FOR THE PRODUCTION OF BIODEGRADEABLE, FUNCTIONALISED POLYMER PARTICLES, AND USE THEREOF AS PHARMACEUTICAL SUPPORTS
#1072Pharmaceutical composition with improved bioavailability
#1073Second generation fatty acid compositions, formulations, and methods of use and synthesis thereof
#1074Formulation of indomethacin
#1075Method for solubilising, dispersing and stabilising of substances, products manufactured according to the method as well as the use thereof
#1076BIODEGRADABLE CARRIER WITH ADJUSTABLE ZETA POTENTIALS AND PARTICLE SIZES, METHOD FOR MAKING THE SAME, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME
#1077Delivery of biologic therapeutics
#1078METHOD FOR MAKING CUSTOMISED NANOPARTICLES, NANOPARTICLES AND USES THEREOF
#1079Continuous flow production of gelatin nanoparticles
#1080GELATIN-BASED MICROGELS
#1081Bioavailable compositions of amorphous piperidinyl compounds
#1082POLYMER BLEND PARTICLES FOR INTRACELLULAR DELIVERY OF AGENTS
#1083Non-irritating benzoyl peroxide
#1084Process for forming amorphous atorvastatin
#1085Solid ganaxolone compositions and methods for the making and use thereof
#1086Highly loaded amorphous efavirenz composition and process for preparing the same
#1087Hypoxia-responsive nanoparticle for therapy and imaging of hypoxia-involving diseases
#1088Antifungal compositions with improved bioavailability
#1089MEDICAL DEVICES INCORPORATING COLLAGEN INHIBITORS
#1090BIO-COMPATIBLE NANO-POLYMER PARTICLES COMPRISING ACTIVE INGREDIENTS FOR PULMONARY APPLICATION
#1091METASTABLE SILVER NANOPARTICLE COMPOSITES
#1092Compositions comprising methylphenidate complexed with ion-exchange resin particles
#1093Reduction of flake-like aggregation in nanoparticulate active agent compositions
#1094Medicinal carriers, and preparation method and uses thereof
#1095Mucoadhesive particulate formulation for inducing antigen-specific immune tolerance
#1096Compressed chewing gum tablet
#1097CELLULOSE-BASED NANOPARTICLES FOR DRUG DELIVERY
#1098NANOPARTICLES BASED FOR DERMAL AND SYSTEMIC DELIVERY OF DRUGS
#1099Thyroid hormone analogs and methods of use
#1100Methods of treating cancer
#1101Block Copolymer For Intraperitoneal Administration Containing Anti-Cancer Agent, Micelle Preparation Thereof, And Cancer Therapeutic Agent Comprising The Micelle Preparation As Active Ingredient
#1102Oral dosage forms of methyl hydrogen fumarate and prodrugs thereof
#1103Enhanced Carriers For The Delivery of Microparticles To Bodily Tissues And Fluids
#1104METHOD FOR PRODUCING DRUG-LOADED POLYMERIC NANOPARTICLES BY POLYMERIZATION IN PRESENCE OF DRUGS
#1105CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS
#1106Extended-Release Levetiracetam and Method of Preparation
#1107Compositions and methods of delivery of pharmacological agents
#1108Compositions and methods of delivery of pharmacological agents
#1109STABILIZED TACROLIMUS COMPOSITION
#1110Method for producing a composite organic compound powder for medical use
#1111Compositions comprising methylphenidate complexed with ion-exchange resin particles
#1112NANODISPERSION
#1113Therapeutic polymeric nanoparticle compositions with high glass transition temperature or high molecular weight copolymers
#1114Drug Delivery Systems
#1115PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ACUTE DISORDERS
#1116ENCAPSULATED OILS
#1117Activated Nucleoside Analog Conjugates and Methods of Use Thereof
#1118Process for producing cellulose derivatives of high bulk density and good flowability
#1119METHODS AND COMPOSITIONS FOR TREEATING PROLIFERATIVE DISEASES
#1120Method for making homogeneous spray-dried solid amorphous drug dispersions utilizing modified spray-drying apparatus
#1121Formulations
#1122Compositions and methods of treating therapy resistant cancer and uses thereof
#1123Abuse deterrent pharmaceutical compositions for controlled release
#1124Itraconazole compositions with improved bioavailability
#1125POLYAMIDE-AMINE DENDRIMER OR DERIVATIVE THEREOF-MATH1 GENE NANO PARTICLE AND USE THEREOF IN TREATMENT OF HEARING LOSS
#1126Orally effective methylphenidate extended release powder and aqueous suspension product
#1127Active-ingredient-containing solid dispersions based on diethylaminoethyl methacrylate copolymers
#1128Oral particle consisting of an amorphous structure and a submicron domain
#1129Coated Nanoparticle Therapy for Skin Cancer
#1130NON-VIRAL NANOPARTICLE-BASED DELIVERY SYSTEM
#1131Collagen-targeted nanoparticles
#1132INJECTABLE BIODEGRADABLE PARTICLES FOR CONTROLLED THERAPEUTIC AGENT RELEASE
#1133Absorbent dressings with painkilling activity
#1134POLYMERIC MICROPARTICLES
#1135MULTICOMPARTMENTALIZED VESICULAR STRUCTURE AND A METHOD FOR FORMING THE SAME
#1136Thermo-kinetic mixing for pharmaceutical applications
#1137Polymorph compositions, methods of making, and uses thereof
#1138Systems and methods for superdisintegrant-based composite particles for dispersion and dissolution of agents
#1139Method for manufacturing acid pellets
#1140Liquid ganaxolone formulations and methods for the making and use thereof
#1141Solid molecular dispersion of fesoterodine hydrogen fumarate and polymeric binder
#1142Soluble needle arrays for delivery of influenza vaccines
#1143Drug loaded polymeric nanoparticles and methods of making and using same
#1144MICROPARTICLES CONTAINING PHYSIOLOGICALLY ACTIVE PEPTIDE, METHOD FOR PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME
#1145Drug-delivery systems
#1146Methods and systems for generating nanoparticles
#1147Cancer cell targeting using nanoparticles
#1148Cancer cell targeting using nanoparticles
#1149Product
#1150Compositions and methods of delivery of pharmacological agents
#1151Composition comprising a mixture of dextro- and levo-amphetamines complexed with ion-exchange resin particles to form drug resin particles
#1152Compositions and their use to treat complications of aneurysmal subarachnoid hemorrhage
#1153Poly(vinyl benzoate) nanoparticles for molecular delivery
#1154Method for treating ADD or ADHD comprising administering amphetamine complexed with ion-exchange resin particles
#1155PHARMACEUTICAL MICROPARTICLES
#1156Drug loaded polymeric nanoparticles and methods of making and using same
#1157Drug loaded polymeric nanoparticles and methods of making and using same
#1158PARTICLES CONSISTING OF A CHITOSAN POLYELECTROLYTE COMPLEX AND OF AN ANIONIC POLYSACCHARIDE, AND HAVING IMPROVED STABILITY
#1159Combinations and modes of administration of therapeutic agents and combination therapy
#1160Methods and formulations for administration of resolvin anti-inflammatory compounds
#1161Treatment of back pain by injection of microparticles of dexamethasone acetate and a polymer
#1162Vitamin E formulations of sulfamide NS3 inhibitors
#1163Fat-reducing agent
#1164Solid dispersion preparation
#1165Nanoparticle-Based Targeted Drug Delivery For In Vivo Bone Loss Mitigation
#1166Co-processing method and formulations for HIV attachment inhibitor prodrug compound and excipients
#1167Snuff composition
#1168Sustained drug release and improved product stability using non-covalent particle coating methods
#1169Rapamycin composition
#1170Functional, cross-linked nanostructures for tandem optical imaging and therapy
#1171Nanoparticles for Targeted Delivery of Active Agents to the Lung
#1172Compositions and methods for delivery of poorly soluble drugs
#1173Method of treating malignant solid tumors
#1174Iron oxide nanoparticles for use in treating non-infectious inflammatory disorders
#1175Dronedarone solid dispersion and preparation method thereof
#1176Engineering of polymer-stabilized nanoparticles for drugs with Log P values below 6 by controlled antisolvent precipitation
#1177Nano-hybrid delivery system for sequential utilization of passive and active targeting
#1178Water-dispersible oral, parenteral, and topical formulations for poorly water soluble drugs using smart polymeric nanoparticles
#1179Therapeutic Polymeric Nanoparticles Comprising Epothilone and Methods of Making and Using Same
#1180Hydroxypropyl methyl cellulose acetate succinate with enhanced acetate and succinate substitution
#1181Tolvaptan solid dispersion and its preparation method
#1182NANOPARTICULATE FORMULATIONS OF MITHRAMYCIN OR MITHRAMYCIN ANALOGUES FOR TREATING CANCER
#1183SOLID DISPERSION COMPRISING AN ANTI-HIV AGENT
#1184Self-assembled toroidal-spiral particles and manufacture and uses thereof
#1185Method for producing an immediately decomposing oral form of administration which releases active ingredients
#1186Gastroretentive Solid Oral Dosage Forms with Swellable Hydrophilic Polymer
#1187Composition of matter for delivering lipid-soluble materials, and a method for producing it
#1188Pharmaceutical composition for improving dissolution rate of prasugrel and its preparation method
#1189CALCIPOTRIOL MONOHYDRATE NANOCRYSTALS
#1190Prasugrel in micronized, crystalline form and pharmaceutical composition thereof
#1191Solid dispersion formulations and methods of use thereof
#1192Process for preparing pharmaceutical compositions of fingolimod
#1193Pharmaceutical solid dispersions
#1194Solid pharmaceutical dosage form of ticagrelor
#1195Compositions comprising polyglutamic acid nanoparticles and CD40 agonists
#1196Stabilized Amorphous Forms of Imatinib Mesylate
#1197SALTS OF FENOFIBRIC ACID AND PHARMACEUTICAL FORMULATIONS THEREOF
#1198PHARMACEUTICAL FORMULATION CONTAINING PHENYTOIN SODIUM AND MAGNESIUM STEARATE
#1199CONTROLLED RELEASE NANOPARTICULATE COMPOSITIONS
#1200METHODS AND COMPOSITIONS FOR DETERRING ABUSE OF ORALLY ADMINISTERED PHARMACEUTICAL PRODUCTS